Guggenheim Capital’s BlackRock Health Sciences Trust BME Stock Holding History

Guggenheim Capital’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,024	Closed	-$328K	–	1870
2024 Q2	$328K	Sell	8,024 -1,440	-15%	-$57.3K	﹤0.01%	1617
2024 Q1	$392K	Sell	9,464 -2,500	-21%	-$105K	﹤0.01%	1572
2023 Q4	$484K	Sell	11,964 -1,479	-11%	-$56.5K	﹤0.01%	1461
2023 Q3	$526K	Buy	13,443 +116	+0.9%	+$4.62K	﹤0.01%	1394
2023 Q2	$542K	Sell	13,327 -76	-0.6%	-$3.13K	﹤0.01%	1436
2023 Q1	$561K	Buy	13,403 +4,047	+43%	+$170K	﹤0.01%	1449
2022 Q4	$408K	Buy	9,356 +3,692	+65%	+$157K	﹤0.01%	1571
2022 Q3	$220K	Buy	5,664 +408	+8%	+$17.4K	﹤0.01%	1761
2022 Q2	$223K	Buy	+5,256	New	+$228K	﹤0.01%	1902

Other funds holding BME

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return

Guggenheim Capital's BME Position: Q3 2024 in Review

Guggenheim Capital sold out of BlackRock Health Sciences Trust (BME) in Q3 2024, closing a stake of 8,024 shares — an estimated $328K sold.

Guggenheim Capital first reported a position in BME in Q2 2022 and held it in 9 quarters. The position peaked at $561K in Q1 2023. 73 funds tracked by Wall St. Rank hold BME as of Q3 2024.

Guggenheim Capital reported no remaining BlackRock Health Sciences Trust position as of Q3 2024 after selling out during the quarter.
Guggenheim Capital sold 8,024 BlackRock Health Sciences Trust shares in Q3 2024, an estimated $328K.
Guggenheim Capital first reported a position in BlackRock Health Sciences Trust in Q2 2022 and held it in 9 quarters.
Guggenheim Capital's BlackRock Health Sciences Trust position peaked at $561K in Q1 2023.
73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2024.

Based on Guggenheim Capital's 13F filing for Q3 2024, filed 13 Nov 2024.